Crowdonomics
WatchlistPortfolio
Eliaz Therapeutics

Reg CF · Class B Common Stock · Jun 2026

OpenReached targetReg CFCommon Equity
via DealMaker · last checked Oct 8, 2026View campaign
Raised
$228.5K / $3M max
8% of ceiling · target hit day 90
Investors
16
$14.3K avg
Momentum
$2K/day
best $33K · 188 days left

Raised over time

Cumulative raisedInvestors
$228K$114K$0
1680
Jun 10, 2026 · openedOct 8, 2026 · latest
Target ($10K) hit — Sep 8, 2026, day 90Deadline Apr 15, 2027 — 189 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via DealMaker, last checked Oct 8, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2024–FY2025 · hover for source
$302K
−$955K
FY2024
$332K
−$1.7M
FY2025
RevenueNet income
Metric
FY2024 audited
FY2025 audited
Income statement
Revenue
$302,481
$332,235
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$954,869
-$1,745,041
Taxes paid
$0
$0
Balance sheet
Cash
$32,814
$1,799,510
Accounts receivable
$0
$0
Total assets
$738,015
$2,589,276
Short-term debt
$2,346,085
$1,796,731
Long-term debt
$3,888,186
$8,033,117
Total liabilities
$6,234,271
$9,829,848
Other
Headcount
5
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$59.4M
Price / share$5.56
Shares offered1,747

Post-money is computed as pre-money + amount raised, so it moves while the round is open — it’s shown once the round closes.

Offering details

Target$10,005
Max$2,999,996
Min investment—
OpenedJun 10, 2026
DeadlineApr 15, 2027
Days active121
Days to deadline188

Links & provenance

Campaign pageSEC filing
Source: SEC EDGAR
0001872856-26-000220
Last synced Oct 2, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.